Literature DB >> 17848483

Current state of endovascular treatment of femoro-popliteal artery disease.

Thomas Zeller1.   

Abstract

Considerable advances have been made over the last decade in percutaneous technology for the treatment of atherosclerotic diseases in the femoro-popliteal arteries. While treatment strategies are well defined in the iliac segment, where angioplasty and stenting perform well in appropriately selected lesions, the search for a durable transcatheter therapy for femoro-popliteal lesions continues. Whereas balloon angioplasty (PTA) is the accepted therapy for short lesions, long diffuse lesions are still recommended for surgical treatment. However, attractive new technologies ranging from transcatheter plaque excision to laser ablation, rotational atherectomy, cryoplasty, brachytherapy, and placement of drug-eluting stents to simple angioplasty with drug-coated balloons may have the potential to replace femoro-popliteal bypass surgery as a treatment of choice for complex lesions. This article reviews the status of percutaneous endovascular techniques for the treatment of femoro-popliteal artery occlusive disease.

Entities:  

Mesh:

Year:  2007        PMID: 17848483     DOI: 10.1177/1358863X07079823

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  14 in total

Review 1.  [Subintimal recanalization. Indications, technique and results].

Authors:  B Radeleff; M Sumkauskaite; N Kortes; D Gnutzmann; T Mokry; H U Kauczor; U Stampfl
Journal:  Radiologe       Date:  2016-03       Impact factor: 0.635

Review 2.  Endovascular intervention for peripheral artery disease.

Authors:  Arun K Thukkani; Scott Kinlay
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

3.  Compound C inhibits vascular smooth muscle cell proliferation and migration in an AMP-activated protein kinase-independent fashion.

Authors:  Kelly J Peyton; Yajie Yu; Benjamin Yates; Ahmad R Shebib; Xiao-ming Liu; Hong Wang; William Durante
Journal:  J Pharmacol Exp Ther       Date:  2011-05-12       Impact factor: 4.030

4.  Noninvasive management of the diabetic foot with critical limb ischemia: current options and future perspectives.

Authors:  Mathias Weck; Torsten Slesaczeck; Hannes Rietzsch; Dirk Münch; Thomas Nanning; Hartmut Paetzold; Hans-Joachim Florek; Andreas Barthel; Norbert Weiss; Stefan Bornstein
Journal:  Ther Adv Endocrinol Metab       Date:  2011-12       Impact factor: 3.565

5.  State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?

Authors:  Ramya C Mosarla; Ehrin Armstrong; Yonatan Bitton-Faiwiszewski; Peter A Schneider; Eric A Secemsky
Journal:  J Soc Cardiovasc Angiogr Interv       Date:  2022-08-20

Review 6.  [New stent developments for peripheral arterial occlusive disease].

Authors:  G Tepe
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

7.  Long-term results of endovascular reconstruction for aortoiliac occlusive disease.

Authors:  Min Yang; Bihui Zhang; Guochen Niu; Ziguang Yan; Xiaoqiang Tong; Yinghua Zou
Journal:  Quant Imaging Med Surg       Date:  2021-04

8.  Evaluation of the role of peripheral artery plaque geometry and composition on stent performance.

Authors:  Christopher Noble; Kent D Carlson; Erica Neumann; Sean Doherty; Dan Dragomir-Daescu; Amir Lerman; Ahmet Erdemir; Melissa Young
Journal:  J Mech Behav Biomed Mater       Date:  2021-01-25

9.  DISCOVER: Dutch Iliac Stent trial: COVERed balloon-expandable versus uncovered balloon-expandable stents in the common iliac artery: study protocol for a randomized controlled trial.

Authors:  Joost A Bekken; Jan Albert Vos; Ruud A Aarts; Jean-Paul P M de Vries; Bram Fioole
Journal:  Trials       Date:  2012-11-19       Impact factor: 2.279

10.  Transpopliteal balloon-assisted excimer-laser atherectomy for the treatment of chronic femoropopliteal occlusions: feasibility and initial results.

Authors:  Christopher W Lüdtke; Fabian Scheer; Peter Kamusella; Christian Wissgott; Reimer Andresen
Journal:  Clin Med Insights Cardiol       Date:  2015-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.